LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-19
Case ID: NM_000314.8_c.634_1_634_3del_20261119_190014
Framework: ACMG/AMP 2015
Variant classification summary

NM_000314.8:c.634+1_634+3del

PTEN  · NP_000305.3:p.?  · NM_000314.8
GRCh37: chr10:89712015 CAGT>C  ·  GRCh38: chr10:87952258 CAGT>C
Gene: PTEN Transcript: NM_000314.8
Final call
Likely Pathogenic
PVS1 very strong PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.?
gnomAD AF
ClinVar
OncoKB
Interpretation summary
Generated evidence synthesis
1
PVS1 very strong: the exon 6 donor disruption causes a frameshifting exon skip predicted to undergo nonsense-mediated decay.
2
PM2 supporting: the variant is absent from gnomAD v2.1 and v4.1.
Final determination: The PTEN Expert Panel Version 3.2 Rule20 is satisfied by one very strong pathogenic criterion and one supporting pathogenic criterion, producing a Likely Pathogenic classification.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Met Met, very strong: exon 6 donor disruption causes a 142-nucleotide frameshifting skip 5' of p.D375 in NM_000314.8, matching the VCEP's full PVS1 path.
cspec vcep_pvs1_decisiontree_pten pvs1_variant_assessment PMID:28677221 PMID:16014636
PS1 Not assessed Not assessed: a nearby c.634+1G>C splice variant causes exon 6 skipping, but pathogenic status and a comparable in-silico result are unavailable.
cspec PMID:28677221
PS2 Not assessed Not assessed: no documented proband, confirmed maternity and paternity, or family-history information establishes a de novo observation.
cspec
PS3 Not assessed Not assessed: no damaging RNA, mini-gene, or other splicing-assay result is available for this canonical splice-site deletion.
vcep_mmc2 PMID:29706350 cspec
PS4 Not assessed Not assessed: no affected-case counts, matched controls, or proband phenotype-specificity scores are available to evaluate the PTEN PS4 rule.
cspec PMID:28677221 PMID:23470840 PMID:39316756 PMID:16014636 gnomad_v2 gnomad_v4
PM1 N/A Not applicable: the canonical splice-site deletion has protein consequence p.? and no amino-acid residue to compare with the PM1 intervals 90-94, 123-130, and 166-168.
cspec
PM2 Met Met, supporting: the variant is absent from gnomAD v2.1 and v4.1, satisfying the VCEP PM2 requirement of less than 0.00001 (0.001%) allele frequency.
cspec gnomad_v2 gnomad_v4
PM3 N/A Not applicable: the PTEN VCEP specification explicitly designates PM3 as not applicable.
cspec
PM4 N/A Not applicable: the variant is a frameshifting canonical splice disruption, not an in-frame indel affecting a catalytic motif or a stop-loss extension.
cspec
PM5 N/A Not applicable: PM5 requires a missense change at an amino-acid residue, whereas this variant is a canonical splice-site deletion with protein consequence p.?.
cspec
PM6 Not assessed Not assessed: no assumed de novo proband observation with parental-confirmation status and no-family-history evidence is documented.
cspec
PP1 Not assessed Not assessed: no affected-family co-segregation observations or meioses are documented against the VCEP minimum of 3 meioses.
cspec
PP2 N/A Not applicable: PP2 is restricted to missense variants, while this variant is a canonical splice-site deletion with protein consequence p.?.
cspec
PP3 Not assessed Not assessed: SpliceAI max delta 0.99 supports impact, but the VCEP requires concordant VarSeak class 4 or 5 and no VarSeak result is available.
cspec spliceai
PP4 N/A Not applicable: the PTEN VCEP incorporates phenotype specificity into PS4 Use 2 and explicitly excludes separate PP4 application.
cspec
PP5 N/A Not applicable: the PTEN VCEP explicitly prohibits PP5 use under its governing specification.
cspec
BA1 Not met Not met: the variant is absent from gnomAD v2.1 and v4.1, rather than exceeding the VCEP BA1 threshold of 0.00056 (0.056%).
cspec gnomad_v2 gnomad_v4
BS1 Not met Not met: the variant is absent from gnomAD v2.1 and v4.1, with no allele frequency in either VCEP BS1 interval of 0.0000043 to 0.00056.
cspec gnomad_v2 gnomad_v4
BS2 Not met Not met: gnomAD v2.1 and v4.1 report no variant observations, so there is no qualifying homozygous observation in a healthy or PHTS-unaffected individual.
cspec gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: no RNA, mini-gene, or other splicing assay demonstrates that this canonical splice-site deletion has no splicing impact.
vcep_mmc2 PMID:29706350 cspec
BS4 Not assessed Not assessed: no affected relatives lacking the variant or family-level non-segregation observations are documented.
cspec
BP1 N/A Not applicable: the ClinGen PTEN VCEP marks BP1 as Not Applicable.
cspec
BP2 Not assessed Not assessed: no qualifying trans observation or at least three cis/phase-unknown observations with different pathogenic PTEN variants are documented.
cspec
BP3 N/A Not applicable: the PTEN VCEP explicitly marks BP3 as Not Applicable, and this splice-site loss-of-function variant is outside that criterion.
cspec
BP4 Not met Not met: SpliceAI max delta 0.99 exceeds the VCEP BP4 benign range of 0-0.2, and VarSeak concordance is unavailable.
cspec spliceai
BP5 Not assessed Not assessed: no two qualifying cases with an alternate highly penetrant molecular diagnosis and non-overlapping PTEN history are documented.
cspec
BP6 N/A Not applicable: the PTEN VCEP explicitly prohibits BP6 use under its governing specification.
cspec
BP7 N/A Not applicable: the intronic deletion is at the canonical +1 splice donor, not at or beyond the VCEP BP7 boundary of +7/-21.
cspec
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.